Crif1 is a novel transcriptional coactivator of STAT3
暂无分享,去创建一个
Bon-Kyoung Koo | Ki Cheol Park | Sun-Kyoung Im | Ki-Jun Yoon | Y. Kong | S. Jang | Jaewang Ghim | M. Shong | B. Koo | Min-chul Kwon | Ki-Jun Yoon | Sun-Kyoung Im | Sung Key Jang | Namshik Kim | Min-chul Kwon | Jin-Sook Moon | Yoon-Young Kim | Nam-Shik Kim | Mi Yi Kwon | Myung-Phil Kong | Jaewang Ghim | Yong-Mahn Han | Minho Shong | Young-Yun Kong | Yoon-Young Kim | Jin-Sook Moon | Yong-Mahn Han | Myung-Phil Kong | Ki Cheol Park | M. Y. Kwon
[1] J. Bromberg. Activation of STAT proteins and growth control , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[2] J. Darnell,et al. Independent and Cooperative Activation of Chromosomal c-fos Promoter by STAT3* , 2003, The Journal of Biological Chemistry.
[3] S. Bhattacharya,et al. Regulation of Stat3 nuclear export. , 2003, The Journal of clinical investigation.
[4] A. Smith,et al. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.
[5] T. Taniguchi,et al. Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1 , 1989, Nature.
[6] J. Darnell,et al. Essential Role of STAT3 in Postnatal Survival and Growth Revealed by Mice Lacking STAT3 Serine 727 Phosphorylation , 2004, Molecular and Cellular Biology.
[7] W. Guida,et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity , 2007, Proceedings of the National Academy of Sciences.
[8] K. Shuai,et al. Modulation of STAT signaling by STAT-interacting proteins , 2000, Oncogene.
[9] D. Levy,et al. Malignant transformation but not normal cell growth depends on signal transducer and activator of transcription 3. , 2005, Cancer research.
[10] T. Taniguchi,et al. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. , 1989, Nature.
[11] J. Turkson,et al. Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen. , 2005, Molecular biology of the cell.
[12] A. Fornace,et al. Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis , 2005, Oncogene.
[13] William F. Morgan,et al. Genomic instability in Gadd45a-deficient mice , 1999, Nature Genetics.
[14] J. Darnell,et al. Stat3 as an Oncogene , 1999, Cell.
[15] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[16] Guochang Huang,et al. GRIM‐19, a death‐regulatory gene product, suppresses Stat3 activity via functional interaction , 2003, The EMBO journal.
[17] G. Linette,et al. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). , 1995, Science.
[18] Hua Yu,et al. Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment , 2007, Nature Reviews Immunology.
[19] Jing Ma,et al. A Novel Sequence in the Coiled-coil Domain of Stat3 Essential for Its Nuclear Translocation* , 2003, Journal of Biological Chemistry.
[20] Jianyuan Luo,et al. Activation of Stat3 Sequence-specific DNA Binding and Transcription by p300/CREB-binding Protein-mediated Acetylation* , 2005, Journal of Biological Chemistry.
[21] K. Shiota,et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Hofmann,et al. Interaction of human papillomavirus type 16 L2 with cellular proteins: identification of novel nuclear body-associated proteins. , 2002, Virology.
[23] Allard Kaptein,et al. Dominant Negative Stat3 Mutant Inhibits Interleukin-6-induced Jak-STAT Signal Transduction (*) , 1996, The Journal of Biological Chemistry.
[24] Xinmin Cao,et al. The Coiled-Coil Domain of Stat3 Is Essential for Its SH2 Domain-Mediated Receptor Binding and Subsequent Activation Induced by Epidermal Growth Factor and Interleukin-6 , 2000, Molecular and Cellular Biology.
[25] C. Caldas,et al. p300/CBP and cancer , 2004, Oncogene.
[26] K. Kuropatwinski,et al. Influence of Subunit Combinations on Signaling by Receptors for Oncostatin M, Leukemia Inhibitory Factor, and Interleukin-6* , 1997, The Journal of Biological Chemistry.
[27] D. Levy,et al. IL-6 signaling via the STAT3/SOCS3 pathway: Functional Analysis of the Conserved STAT3 N-domain , 2006, Molecular and Cellular Biochemistry.
[28] D. Levy,et al. What does Stat3 do? , 2002, The Journal of clinical investigation.
[29] T. Ouchi,et al. STAT1-induced Apoptosis Is Mediated by Caspases 2, 3, and 7* , 2004, Journal of Biological Chemistry.
[30] P. Heinrich,et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.
[31] A. Miyajima,et al. A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3 , 2002, The EMBO journal.
[32] S. Akira,et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] Fred Schaper,et al. The zinc finger protein Gfi‐1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3 , 2000, The EMBO journal.
[34] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[35] P Jay,et al. Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.
[36] Wei He,et al. The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] K. Miyazono,et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. , 1999, Science.
[38] J. Herman,et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity , 2001, Nature Genetics.
[39] Jung Hun Song,et al. CR6-interacting Factor 1 Interacts with Gadd45 Family Proteins and Modulates the Cell Cycle* , 2003, Journal of Biological Chemistry.
[40] W. Alexander,et al. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. , 2004, Annual review of immunology.
[41] R. Jove,et al. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[42] M. Boothby,et al. Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Miyazaki,et al. Tissue-Specific Autoregulation of thestat3 Gene and Its Role in Interleukin-6-Induced Survival Signals in T Cells , 2001, Molecular and Cellular Biology.
[44] C. Litterst,et al. An LXXLL Motif in the Transactivation Domain of STAT6 Mediates Recruitment of NCoA-1/SRC-1* , 2002, The Journal of Biological Chemistry.
[45] Jung Hun Song,et al. CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation. , 2005, Molecular endocrinology.
[46] D. Levy,et al. New and Old Functions of STAT3: A Pivitol Target for Individualized Treatment of Cancer , 2005, Cell cycle.
[47] H. Gascan,et al. Functional Interaction of STAT3 Transcription Factor with the Coactivator NcoA/SRC1a* , 2002, The Journal of Biological Chemistry.